Company Filing History:
Years Active: 2015
Title: Silla Semballa: Innovator in Antigenic Structures for Trypanosomiasis Screening
Introduction
Silla Semballa is a notable inventor based in Bangul, Central African Republic. She has made significant contributions to the field of biomedical research, particularly in the development of antigenic structures for screening trypanosomiasis in humans and animals. Her innovative work has the potential to impact public health and veterinary medicine.
Latest Patents
Semballa holds a patent for an invention titled "Antigenic structure and uses thereof for screening trypanosomiases in humans and animals." This invention relates to an antigenic structure that contains a tryptophan epitope. The structure is characterized by a tryptophan pattern W or a peptide of 3 or 4 amino acids comprising a pattern W, coupled with glutaraldehyde. This invention can be utilized for screening trypanosomiasis in both humans and animals, showcasing her commitment to advancing medical diagnostics.
Career Highlights
Silla Semballa is affiliated with the Centre de Cooperation Internationale en Recherche Agronomique pour le Développement (CIRAD). Her role at this esteemed research institution allows her to collaborate with other experts in the field and contribute to significant advancements in agricultural and health-related research.
Collaborations
Semballa has worked alongside notable colleagues such as Philippe Holzmuller and Philippe Vincendeau. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Silla Semballa's innovative work in antigenic structures represents a significant advancement in the screening of trypanosomiasis. Her contributions to the field highlight the importance of research in improving health outcomes for both humans and animals.